Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
Read SH, Kerssens JJ, McAllister DA, Colhoun HM, Fischbacher CM, Lindsay RS, et al. Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia. 2016;59(10):2106–13.
Article PubMed PubMed Central Google Scholar
Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. Estimated life expectancy in a scottish cohort with type 1 diabetes, 2008–2010. JAMA. 2015;313(1):37–44.
Article CAS PubMed PubMed Central Google Scholar
Negre-Salvayre A, Salvayre R, Augé N, Pamplona R, Portero-Otín M. Hyperglycemia and glycation in Diabetic Complications. Antioxidants & Redox Signaling. 2009;11(12):3071–109.
Rampin A, Carrabba M, Mutoli M, Eman CL, Testa G, Madeddu P, et al. Recent advances in KEAP1/NRF2-Targeting strategies by Phytochemical Antioxidants, Nanoparticles, and Biocompatible Scaffolds for the treatment of Diabetic Cardiovascular Complications. Antioxid Redox Signal. 2022;36(10–12):707–28.
Article CAS PubMed Google Scholar
Santopaolo M, Sambataro M, Spinetti G, Madeddu P. Bone marrow as a target and accomplice of vascular complications in diabetes. Diabetes Metab Res Rev. 2020;36 Suppl 1:e3240.
Wang Y, Shao T, Wang J, Huang X, Deng X, Cao Y, et al. An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage. Biomed Pharmacother. 2021;133:110991.
Article CAS PubMed Google Scholar
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88.
Article CAS PubMed Google Scholar
Tresierra-Ayala MÁ, García Rojas A. Association between peripheral arterial disease and diabetic foot ulcers in patients with diabetes mellitus type 2. Medicina Universitaria. 2017;19(76):123–6.
Ferraro F, Lymperi S, Mendez-Ferrer S, Saez B, Spencer JA, Yeap BY, et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med. 2011;3(104):104ra1.
Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–27.
Article CAS PubMed PubMed Central Google Scholar
Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the Immune System. Curr Diabetes Rev. 2020;16(5):442–9.
PubMed PubMed Central Google Scholar
Palano MT, Cucchiara M, Gallazzi M, Riccio F, Mortara L, Gensini GF, et al. When a friend becomes your enemy: natural killer cells in atherosclerosis and Atherosclerosis-Associated Risk factors. Front Immunol. 2021;12:798155.
Article CAS PubMed Google Scholar
Spinetti G, Sangalli E, Tagliabue E, Maselli D, Colpani O, Ferland-McCollough D, et al. MicroRNA-21/PDCD4 Proapoptotic Signaling from circulating CD34(+) cells to vascular endothelial cells: a potential contributor to adverse Cardiovascular Outcomes in patients with critical limb ischemia. Diabetes Care. 2020;43(7):1520–9.
Article CAS PubMed PubMed Central Google Scholar
Pezhman L, Tahrani A, Chimen M. Dysregulation of leukocyte trafficking in type 2 diabetes: mechanisms and potential therapeutic avenues. Front Cell Dev Biol. 2021;9:624184.
Article PubMed PubMed Central Google Scholar
Jansen F, Li Q, Pfeifer A, Werner N. Endothelial- and Immune Cell-Derived Extracellular vesicles in the regulation of Cardiovascular Health and Disease. JACC Basic Transl Sci. 2017;2(6):790–807.
Article PubMed PubMed Central Google Scholar
Schober A, Blay RM, Saboor Maleki S, Zahedi F, Winklmaier AE, Kakar MY, et al. MicroRNA-21 controls circadian regulation of apoptosis in atherosclerotic lesions. Circulation. 2021;144(13):1059–73.
Article CAS PubMed Google Scholar
Poller W, Dimmeler S, Heymans S, Zeller T, Haas J, Karakas M, et al. Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur Heart J. 2018;39(29):2704–16.
Article CAS PubMed Google Scholar
Robinson EL, Baker AH, Brittan M, McCracken I, Condorelli G, Emanueli C, et al. Dissecting the transcriptome in cardiovascular disease. Cardiovasc Res. 2022;118(4):1004–19.
Article CAS PubMed Google Scholar
Gomes CPC, Schroen B, Kuster GM, Robinson EL, Ford K, Squire IB, et al. Regulatory RNAs in Heart Failure. Circulation. 2020;141(4):313–28.
Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20–51.
Article CAS PubMed PubMed Central Google Scholar
van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012;11(11):860–72.
Article PubMed PubMed Central Google Scholar
Ni WJ, Leng XM. Dynamic miRNA-mRNA paradigms: new faces of miRNAs. Biochem Biophys Rep. 2015;4:337–41.
PubMed PubMed Central Google Scholar
van der Kwast R, van Ingen E, Parma L, Peters HAB, Quax PHA, Nossent AY. Adenosine-to-inosine editing of MicroRNA-487b alters Target Gene Selection after Ischemia and promotes neovascularization. Circ Res. 2018;122(3):444–56.
van der Kwast R, Woudenberg T, Quax PHA, Nossent AY. MicroRNA-411 and its 5’-IsomiR have distinct targets and functions and are differentially regulated in the vasculature under Ischemia. Mol Ther. 2020;28(1):157–70.
Chamorro-Jorganes A, Sweaad WK, Katare R, Besnier M, Anwar M, Beazley-Long N, et al. METTL3 regulates angiogenesis by modulating let-7e-5p and miRNA-18a-5p expression in endothelial cells. Arterioscler Thromb Vasc Biol. 2021;41(6):e325-e37.
Iwasaki YW, Siomi MC, Siomi H. PIWI-Interacting RNA: Its Biogenesis and Functions. Annu Rev Biochem. 2015;84:405–33.
Article CAS PubMed Google Scholar
Scott MS, Ono M. From snoRNA to miRNA: dual function regulatory non-coding RNAs. Biochimie. 2011;93(11):1987–92.
Article CAS PubMed PubMed Central Google Scholar
Kiss T. Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J. 2001;20(14):3617–22.
Article CAS PubMed PubMed Central Google Scholar
Ingen E, Homberg DAL, Bent ML, Mei H, Papac-Milicevic N, Kremer V, et al. C/D box snoRNA SNORD113-6/AF357425 plays a dual role in integrin signalling and arterial fibroblast function via pre-mRNA processing and 2’O-ribose methylation. Hum Mol Genet. 2021.
Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2 C. Science. 2006;311(5758):230–2.
Article CAS PubMed Google Scholar
Håkansson KEJ, Goossens EAC, Trompet S, van Ingen E, de Vries MR, van der Kwast R, et al. Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular disease. Cardiovasc Res. 2019;115(10):1519–32.
Lee J, Harris AN, Holley CL, Mahadevan J, Pyles KD, Lavagnino Z, et al. Rpl13a small nucleolar RNAs regulate systemic glucose metabolism. J Clin Invest. 2016;126(12):4616–25.
Article PubMed PubMed Central Google Scholar
Burnett LC, Hubner G, LeDuc CA, Morabito MV, Carli JFM, Leibel RL. Loss of the imprinted, non-coding Snord116 gene cluster in the interval deleted in the Prader Willi syndrome results in murine neuronal and endocrine pancreatic developmental phenotypes. Hum Mol Genet. 2017;26(23):4606–16.
Article CAS PubMed PubMed Central Google Scholar
Keam SP, Hutvagner G. tRNA-Derived fragments (tRFs): emerging New Roles for an ancient RNA in the regulation of Gene expression. Life (Basel). 2015;5(4):1638–51.
Fu H, Feng J, Liu Q, Sun F, Tie Y, Zhu J, et al. Stress induces tRNA cleavage by angiogenin in mammalian cells. FEBS Lett. 2009;583(2):437–42.
Article CAS PubMed Google Scholar
Su Z, Wilson B, Kumar P, Dutta A. Noncanonical roles of tRNAs: tRNA fragments and Beyond. Annu Rev Genet. 2020;54:47–69.
Article CAS PubMed PubMed Central Google Scholar
Magee R, Rigoutsos I. On the expanding roles of tRNA fragments in modulating cell behavior. Nucleic Acids Res. 2020;48(17):9433–48.
Article CAS PubMed PubMed Central Google Scholar
Winek K, Lobentanzer S, Nadorp B, Dubnov S, Dames C, Jagdmann S, et al. Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockade. Proc Nat
留言 (0)